FDA Approves Rituxan To Treat Two Rare Disorders
Links shared publicly online about this topic.
- 352total visits
FDA Approves Rituxan To Treat Two Rare Disorders
View full resource at medicalnewstoday.com
Tags: Non-Hodgkin Lymphoma Medication, Rheumatoid Arthritis Medication, Disease and Condition, Diet and Nutrition, Drug, FDA, Rituxan
Most Recently Shared on April 20, 2011 at 3:07 pm By:
FDA Approves Rituxan To Treat Two Rare Disorders: The U.S. Food and Drug Administration today approved Rituxan (... http://bit.ly/hj6SfW
Also Shared By:
Shire Ends Fabry Drug Bid, Giving Sanofi A Boost - Forbes
forbes.com — “In a surprise move, Shire Pharmaceuticals has ended its bid for FDA approval for its Replagal biologic for treating Fabry disease, a rare, but life-threatening genetic disorder. The move comes less than two months after the FDA approved a manufacturing plant operated by Genzyme, which experienced shortages of its own medication for the past two years and is now trying to restoring regular supplies.” View full resource at forbes.com
Most Recently Shared on March 15, 2012 at 1:09 pm By:
Drugs and Devices OW OW Health
Shire Ends Fabry Drug Bid, Giving Sanofi A Boost: In a surprise move, Shire Pharmaceuticals has ended its ... http://t.co/9MC2NTKo #drug
Medical News: FDA Okays Drug for Rare Blood Vessel Disorders - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA approved the non-Hodgkin's lymphoma treatment rituximab (Rituxan) for use with steroids in patients with two rare blood-vessel inflammation disorders.” View full resource at medpagetoday.com
Most Recently Shared on April 21, 2011 at 4:17 pm By:
FDA Okays Drug for Rare Blood Vessel Disorders http://bit.ly/fJA9MR
Advertisement
MNT Drug Approvals
@mnt_drugapprov
FDA Approves Rituxan To Treat Two Rare Disorders http://mnt.to/3TRb #regulatory
1 year ago...